Traditionally, drug development has focused on tiny compounds, but amino acid alliances are increasingly receiving attention. This novel methodology embraces combining peptides with other biological methods to address intricate disease mechanisms. By leveraging the distinctive features of peptides – such as high precision and bioavailability –